Keybank National Association OH Has $22.66 Million Stock Holdings in Aflac Incorporated (NYSE:AFL)

Keybank National Association OH decreased its holdings in shares of Aflac Incorporated (NYSE:AFL) by 0.3% in the 1st quarter, Holdings Channel.com reports. The firm owned 203,772 shares of the financial services provider’s stock after selling 588 shares during the quarter. Keybank National Association OH’s holdings in Aflac were worth $22,657,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC lifted its holdings in shares of Aflac by 64.4% during the fourth quarter. Brighton Jones LLC now owns 14,570 shares of the financial services provider’s stock worth $1,507,000 after buying an additional 5,708 shares during the last quarter. Proficio Capital Partners LLC acquired a new stake in shares of Aflac in the fourth quarter worth $192,000. Fisher Asset Management LLC increased its position in Aflac by 6.9% during the fourth quarter. Fisher Asset Management LLC now owns 7,691 shares of the financial services provider’s stock worth $796,000 after acquiring an additional 494 shares during the period. Norden Group LLC increased its position in Aflac by 23.7% during the fourth quarter. Norden Group LLC now owns 2,395 shares of the financial services provider’s stock worth $248,000 after acquiring an additional 459 shares during the period. Finally, SRS Capital Advisors Inc. raised its stake in Aflac by 351.0% during the 4th quarter. SRS Capital Advisors Inc. now owns 460 shares of the financial services provider’s stock valued at $48,000 after purchasing an additional 358 shares during the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

Aflac Stock Performance

Shares of NYSE:AFL opened at $103.51 on Thursday. The business’s fifty day moving average price is $104.41 and its two-hundred day moving average price is $105.21. Aflac Incorporated has a fifty-two week low of $88.00 and a fifty-two week high of $115.50. The stock has a market capitalization of $55.96 billion, a price-to-earnings ratio of 16.17, a price-to-earnings-growth ratio of 3.27 and a beta of 0.81. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.09 and a quick ratio of 0.09.

Aflac (NYSE:AFL) last issued its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing the consensus estimate of $1.67 by ($0.01). Aflac had a net margin of 21.27% and a return on equity of 15.55%. The firm had revenue of $3.40 billion during the quarter, compared to analyst estimates of $4.53 billion. During the same quarter in the prior year, the firm posted $1.66 EPS. The firm’s revenue for the quarter was down 37.5% on a year-over-year basis. As a group, analysts predict that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 2nd. Shareholders of record on Wednesday, May 21st were paid a dividend of $0.58 per share. The ex-dividend date was Wednesday, May 21st. This represents a $2.32 annualized dividend and a yield of 2.24%. Aflac’s dividend payout ratio is 36.25%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. JPMorgan Chase & Co. boosted their price objective on shares of Aflac from $94.00 to $96.00 and gave the stock a “neutral” rating in a report on Wednesday, April 2nd. Wells Fargo & Company lifted their target price on Aflac from $102.00 to $103.00 and gave the stock an “equal weight” rating in a research report on Tuesday, May 6th. Piper Sandler upped their price target on Aflac from $118.00 to $124.00 and gave the company an “overweight” rating in a report on Wednesday, April 2nd. Keefe, Bruyette & Woods raised their price objective on Aflac from $104.00 to $106.00 and gave the stock a “market perform” rating in a research report on Wednesday, May 7th. Finally, Raymond James Financial lowered their price objective on Aflac from $115.00 to $110.00 and set an “outperform” rating on the stock in a research report on Thursday, May 29th. Three analysts have rated the stock with a sell rating, nine have given a hold rating and three have given a buy rating to the company. According to MarketBeat, Aflac currently has a consensus rating of “Hold” and a consensus target price of $106.50.

Insiders Place Their Bets

In related news, Director Masatoshi Koide sold 37,000 shares of the firm’s stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $105.59, for a total transaction of $3,906,830.00. Following the completion of the sale, the director directly owned 70,992 shares of the company’s stock, valued at $7,496,045.28. This trade represents a 34.26% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Arthur Reginald Collins sold 2,750 shares of Aflac stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $105.70, for a total value of $290,675.00. Following the completion of the transaction, the director owned 6,728 shares of the company’s stock, valued at approximately $711,149.60. The trade was a 29.01% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 40,750 shares of company stock valued at $4,304,295. 0.90% of the stock is currently owned by insiders.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.